Foundation Medicine, Eisai, pursue Dx for cancer drug; Beware Chinese device market pitfalls

 @FierceMedDev: AngioDynamics has agreed to purchase Vortex Medical for $55M. News | Follow @FierceMedDev

 @MarkHFierce: Stem cells derived from skin to be tested in humans as eye disease treatment--via Bloomberg. Article | Follow @MarkHFierce

 @DamianFierce: Boston Scientific will pay up to $265M for Rhythmia Medical. News | Follow @DamianFierce

> Foundation Medicine is teaming up with Eisai to handle genomic profiling and diagnostic discovery in a worldwide clinical trial of a cancer treatment. News

> SkelRegen, a startup helmed by a former Medtronic ($MDT) president and the director of Emory University Orthopaedics and Spine Center, is developing molecular compounds to regenerate bone tissue. Article

> The growing Chinese medical device market may seem alluring, but there are many pitfalls that face devicemakers looking to expand into the country, according to a report from Millennium Research Group. More

> The FDA has posted a warning letter citing Hospira ($HSP) for infusion pump manufacturing violations at its Costa Rica facility. Letter

> Navidea Biopharmaceuticals ($NAVB) is touting more positive clinical results for Lymphoseek, its diagnostic aid that has face delays on the path to FDA approval. Item

> Hygieia snagged a CE mark for its d-Nav Diabetes Insulin Guidance System, designed to update insulin dosage as needed. More

> Masimo ($MASI) got 510(k) clearance for its uSpO2 universal pulse oximetry cable, designed for use with GE Healthcare's ($GE) ApexPro Telemetry Systems. Release

> Boston Scientific ($BSX) has launched the Victory guidewire, designed to facilitate the placement of catheters and other devices in the peripheral arteries. Story

Biotech News

 @FierceBiotech: Fight against 'unwarranted' drug patents goes online. FierceBiotechIT article | Follow @FierceBiotech

 @JohnCFierce: Interesting. Twitter conclusion: Solanezumab a complete bust. But on BMBG, Reuters etc., it's an intriguing "win" for patients. Disconnect. | Follow @JohnCFierce

 @RyanMFierce: Magic Johnson is using his celebrity to bring attention to OraSure's at-home HIV test. A good use of his celebrity, I think.  | Follow @RyanMFierce

> Merck to shutter longtime NJ HQ in corporate reshuffle. News

> Billionaire Kirk orchestrates $45M cell therapy tie-up in biotech deal spree. Story

> Merck taps startup from Down Under for vaccine patch. Article

> Eli Lilly surges on conflicting data for Alzheimer's drug solanezumab. Report

Pharma News

@FiercePharma: Scotland rejects Avastin for ovarian cancer. Roche says the Scots need a cancer-drugs fund like England's. Report | Follow @FiercePharma

> Roche: Scotland needs funding for rejected cancer meds. Article

> Merck plots HQ move to former Schering site. More

> J&J eyes new Doxil process to reverse shortage. Story

Pharma Manufacturing News

> Compounder tied to meningitis deaths sold large quantities. News

> Sanofi Pasteur reports more issues with vaccine quality. Story

> Mold found in Hospira dextrose solution. Report

Biotech Research News

> Japanese scientists weld stem cells to create eggs and then baby mice. More

> RXi gains SBIR grant to pursue RNAi eye cancer drug. News

> Athersys stem cell therapy displays power as MS treatment. Article

> Inovio preclinical results prove skin delivery potency for DNA vaccines. Story

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.